Publicaciones en colaboración con investigadores/as de Ospedale San Martino (14)

2023

  1. 2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry

    International Journal of Cardiology, Vol. 390

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism

    Nutrients, Vol. 14, Núm. 9

  3. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. COVID-19-associated pulmonary aspergillosis, March-August 2020

    Emerging Infectious Diseases, Vol. 27, Núm. 4, pp. 1077-1086

  2. Trauma quality indicators: internationally approved core factors for trauma management quality evaluation

    World Journal of Emergency Surgery, Vol. 16, Núm. 1

2020

  1. International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

    Liver International, Vol. 40, Núm. 6, pp. 1467-1476

  2. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 12, pp. 1353-1362

2019

  1. NK cell-based immunotherapy in cancer metastasis

    Cancers, Vol. 11, Núm. 1

2018

  1. KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?

    Annals of Oncology, Vol. 29, pp. ix164

  2. NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines

    Cancer Research, Vol. 78, Núm. 14, pp. 3913-3925

  3. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer

    New England Journal of Medicine, Vol. 378, Núm. 22, pp. 2078-2092

2017

  1. Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents

    Journal of Clinical Oncology, Vol. 35, Núm. 14, pp. 1591-1597

2016

  1. NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

    Journal of Immunology Research, Vol. 2016